Merkel Cell Carcinoma: Prognosis and Treatment of Patients From a Single Institution
Top Cited Papers
- 1 April 2005
- journal article
- surgical oncology
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 23 (10), 2300-2309
- https://doi.org/10.1200/jco.2005.02.329
Abstract
Purpose: Merkel cell carcinoma (MCC) is an uncommon cutaneous malignancy. Most reports consist of single-institution experiences of fewer than 30 patients. The natural history of MCC is poorly defined. Patients and Methods: A review was performed of Memorial Sloan-Kettering Cancer Center's MCC database, identifying 251 patients who had been treated between 1970 and 2002. Patient, tumor, and treatment-related factors were analyzed for their association with recurrence and survival. Results: The average follow-up for all patients was 40 months and 46 months for patients alive at last follow-up. The 5-year disease-specific survival rate was 64%. Disease stage was the only independent predictor of survival (stage I, 81%; stage II, 67%; stage III, 52%; stage IV, 11%; P = .001). Pathologic staging of the draining nodal basin was performed in 71 (40%) of 177 patients who presented with clinically negative nodes, and 16 of these patients (23%) were found to have node-positive disease. Pathologic nodal staging was associated with improved stage-specific survival probabilities (clinical node-negative, 75% v pathologic node-negative disease, 97%; P = .009) and decreased nodal recurrence (44% v 11%, P < .001). The median time to recurrence was 9 months, and 102 patients (43%) recurred. Local recurrence developed in 8% of patients after margin-negative excision. Conclusion: These data demonstrate that the natural history of MCC is variable and dependent on the stage of disease at presentation. Pathologic nodal staging identifies a group of patients with excellent long-term survival. After margin-negative excision and pathologic nodal staging, local and nodal recurrence rates are low.This publication has 22 references indexed in Scilit:
- Radiotherapy Alone for Primary Merkel Cell CarcinomaArchives of Dermatology, 2003
- Local control of primary Merkel cell carcinoma: Review of 45 cases treated with Mohs micrographic surgery with and without adjuvant radiationJournal of the American Academy of Dermatology, 2002
- Multimodality Treatment of Merkel Cell Carcinoma: Case Series and Literature Review of 1024 CasesAnnals of Surgical Oncology, 2001
- Merkel Cell Carcinoma of the Head and NeckJAMA Otolaryngology–Head & Neck Surgery, 2001
- Chemotherapy in Neuroendocrine/Merkel Cell Carcinoma of the Skin: Case Series and Review of 204 CasesJournal of Clinical Oncology, 2000
- Surgical Management of Merkel Cell CarcinomaAnnals of Surgery, 1999
- Cutaneous Neuroendocrine (Merkel Cell) CarcinomaAmerican Journal of Clinical Oncology, 1995
- The importance of postoperative radiation therapy in the treatment of Merkel cell carcinomaInternational Journal of Radiation Oncology*Biology*Physics, 1995
- Merkel Cell CarcinomaArchives of Surgery, 1991
- Trabecular (merkel cell) carcinoma of the skin. Treatment of primary, recurrent, and metastatic diseaseCancer, 1986